<DOC>
	<DOCNO>NCT01598753</DOCNO>
	<brief_summary>This randomize control study involve combination drug treatment , behavioral health , placebo control . Some participant receive medication approve Food Drug Administration treatment moderate moderately severe pain call Tramadol HC1 IR . Others receive inactive pill , call placebo . There also 2 different type behavioral health treatment , Cognitive-Behavior Therapy ( CBT ) Health Education ( HE ) recommend treatment patient FM American Pain Society . There 4 possible study treatment combination : 1 . Tramadol + CBT , 2 . Tramadol + HE , 3 . Placebo + CBT , 4 . Placebo + HE . Although Tramadol , CBT , HE show benefit FM patient , study evaluate combination medication behavioral health treatment . The primary purpose study compare benefit 4 combination list .</brief_summary>
	<brief_title>Combined Behavioral Analgesic Trial Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<criteria>Males Females 2170 Diagnosis Fibromyalgia Current primary care physician Fluent English Rheumatologic disorder Drug alcohol abuse past year Psychiatric hospitalization past 6 month Current use Tramadol Certain antidepressant pain medication</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>